Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy

Magnetic Resonance in Medicine

Volumn 49, Issue 2, 2003, Pages 223-232

  Howe, Franklin A ^a   Barton, S J ^a   Cudlip, S A ^b   Stubbs, M ^a   Saunders, D E ^a   Murphy, M ^b   Wilkins, P ^b   Opstad, K S ^a   Doyle, V L ^a   McLean, M A ^a   Bell, B A ^b   Griffiths, J R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ATKINSON MORLEY S HOSPITAL   (United Kingdom)

Author keywords

1H spectroscopy; Grading; Metabolites; Quantitation; Tumor

Indexed keywords

AMINO ACIDS; BIOMOLECULES; BRAIN; CELL DEATH; GRADING; LIPIDS; MACROMOLECULES; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; METABOLITES;

1H MAGNETIC RESONANCE SPECTROSCOPIES; GLIOBLASTOMAS; HUMAN BRAIN TUMORS; METABOLIC PROFILES; METABOLITE CONCENTRATIONS; PEAK AREA RATIOS; QUANTITATION; SCATTER PLOTS;

TUMORS;

ALANINE; CHOLINE; CREATINE; INOSITOL; LACTIC ACID; LIPID;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; EQUIPMENT; GLIOBLASTOMA; HUMAN; IN VIVO STUDY; MACROMOLECULE; MENINGIOMA; METABOLISM; METABOLITE; METASTASIS; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; TUMOR CLASSIFICATION; TUMOR NECROSIS; WHITE MATTER;

EID: 12244252777     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.10367     Document Type: Article

References (40)

1. Bernstein M, Parrent AG. Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 1994;81:165-168.
2. Preul MC, Caramanos Z, Collins DL, Villemure J-G, Leblanc R, Olivier A, Pokrupa R, Arnold D. Accurate, non-invasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 1996;2:323-325.
3. Wilken B, Dechent P, Herms J, Maxton C, Markakis E, Hanefeld F, Frahm J. Quantitative proton magnetic resonance spectroscopy of focal brain lesions. Pediatr Neurol. 2000;23:22-31.
4. Castillo M, Smith JK, Kwock L. Correlation of myo-Inositol levels and grading of cerebral astrocytomas. Am J Neuroradiol 2000;21:16451649.
5. Lazareff JA, Bockhorst KHJ, Curran J, Olmstead C, Alger JR. Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging. Neurosurgery 1998;43:809-818.
6. Taylor JS, Langston JW, Reddick WE, Kingsley PB, Ogg RJ, Pui MH, Kun LE, Jenkins JJ, Chen G, Ocks JJ, Sanford RA, Heideman RL. Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys 1996;36:1251-1261.
7. Kugel H, Heindel W, Ernestus R-I, Bunke J, du Mesnil R, Friedmann G. Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 1992;183:701-709.
8. Ott D, Hennig J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 1993;186:745-752.
9. Gill SS, Thomas DGT, van Bruggen N, Gadian DG, Peden CJ, Bell JD, Cox IJ, Menon DK, Iles RA, Bryant DJ, Coutts GA. Proton spectroscopy of intracranial tomours: in vivo and in vitro studies. J Comput Assist Tomogr 1990;14:497-504.
10. Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BCP, Mengeot MM, Moser E, Padavic-Shaller KA, Sanders JA, Spraggins TA, Stillman AE, Terwey B, Vogt TJ, Wicklow K, Zimmerman RA. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84:449-458.
11. 1H HR-MAS spectroscopy of intact biopsy samples in vivo. MAGMA 1999;8:121-128.
12. Hagberg G, Burlina AP, Mader I, Roser W, Radue EW, Seelig J. In vivo proton spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification. Magn Reson Med 1995;34:242-252.
13. 1H-MR spectra in the presence of mobile lipids. Magn Reson Med 2001;46:615-618.
14. 1H MRS spectra from brain tumours. NMR Biomed 1998;11:177-191.
15. Tien RD, Lai PH, Smith JS, Lazeyras F. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. Am J Radiol 1996;167:201-209.
16. 1H NMR spectra of human brain. Magn Reson Med 1994;32:294-302.
17. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer 1988;64:2152-2165.
18. Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE. Automated single-voxel proton MRS: technical development and multi-site verification. Magn Reson Med 1994;31:365-373.
19. Vanhamme L, van den Boogart A, van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;29:35-43.
20. Klose U. In vivo proton spectroscopy in the presence of eddy currents. Magn Reson Med 1990;14:26-30.
21. Pijnappel WWF, van den Boogaart A, de Beer R, van Ormondt D. SVD-based quantification of magnetic resonance signals. J Magn Reson 1992;97:122-134.
22. Saunders DE, Howe FA, van den Boogaart A, McClean MA, Griffiths JR, Brown MM. Continuing ischemic damage after acute middle cerebral infarction in humans demonstrated by short echo proton spectroscopy. Stroke 1995;26:1007-1013.
23. 2 mapping: application to the prostate. J Magn Reson Imaging 1996;6:603-607.
24. 1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed 1994;7:149-155.
25. 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis. Nat Med 1999;5:1323-1327.
26. 2 and proton density values: results in 160 patients with brain tumors. Radiology 1988;169:779-785.
27. Manton DJ, Lowry M, Blackband SJ, Horsman A. Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumours. NMR Biomed 1995;8:104-112.
28. 1H NMR spectroscopy in vivo and in vitro. J Neurochem 1994;63:1538-1543.
29. Norfray JF, Tadanori T, Byrd SE, Ross BD, Berger PA, Miller RS. Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors. Am J Radiol 1999;173:119-125.
30. Mader I, Roser W, Hagberg G, Schneider M, Sauter R, Seelig J, Radue EW, Steinbrich W. Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors. MAGMA 1996;4:139-150.
31. Cheng LL, Chang I-Wen, Louis DN, Gonzalez RG. Correlation of highresolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res 1998;58:1825-1832.
32. Barba I, Moreno A, Martinez-Perez, Tate AR, Cabanas ME, Baquero M, Capdevila A, Arus C. Magnetic resonance spectroscopy fo brain hemangiopericytomas: high myoinositol concentrations and discrimination from meningiomas. J Neurosurg 2001;94:55-60.
33. 1H NMRS spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med 1992;24:123-136.
34. Kinoshita Y, Yokota A. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed 1997;10:2-12.
35. 1H MRS. Magn Reson Med 2003: in press.
36. Remy C, Fouilhe N, Barba I, Sam-Lai E, Lahrech H, Cucurella MG, Izquierdo M, Moreno A, Ziegler A, Massarelli R, Decorps M, Arus C. Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets. Cancer Res 1997;57:407-414.
37. Barba I, Cabanas ME, Arus C. The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells. Cancer Res 1999;59:1861-1868.
38. Seeger U, Mader I, Klose U. Nägele T. Parameterized evaluation of pathological macromolecules in proton MR spectra of the human brain. In: Proceedings of the 9th Annual Meeting of ISMRM, Glasgow, Scotland, 2001. p 1659.
39. Cheng LL, Anthony DC, Comite AR, Black PM, Tzika AA, Gonzalez RG. Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. Neuro-Oncol 2000;2:87-95.
40. 1H MRS spectroscopy in patients with metastatic brain tumors: a multicentre study. Magn Reson Med 1995;33:818-826.